Commercialization And Logistics

  1. Solutions For Diverse Biomolecule Purification 5/21/2025

    Interview with Paul Lynch, Product Management Leader, Purification, discusses our chromatography resins and innovations in downstream purification processes.

  2. CTS DynaCellect Magnetic Separation System Cell Isolation 5/22/2025

    Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.

  3. Thermo Fisher Scientific Bio-Expo Live 2024: Downstream Bioprocessing 8/15/2024

    Review downstream process tools from Thermo Fisher Scientific to enable optimal biologics purification, including chromatography resins, chemicals, process liquids, and buffers.

  4. Singapore Single-Use Site Capacity Expansion 6/1/2022

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region

  5. Efficient AAV Purification With AAVx And AAV9 Magnetic Beads 6/30/2025

    Explore an alternative to chromatographic affinity capture that eliminates the need for universal nuclease treatment by utilizing magnetic beads with ligands specific to AAV.

  6. Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics 1/22/2025

    Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

  7. Technology Needs For Automated Manufacturing 8/18/2023

    Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.

  8. Manufacturing Hurdles With Viral Vectors 11/13/2023

    With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and scale-up is critical. In this segment, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO share what they consider to be the most difficult challenges in vector development and manufacturing currently.

  9. Perfusion: Medium Selection And Testing 6/16/2025

    An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

  10. CTS DynaCellect Magnetic Separation System Uninstalling Bead Removal Kit 5/22/2025

    Safely remove the bead removal kit from the CTS DynaCellect Magnetic Separation System. This video shows you how to remove the cassette and fluid lines.